|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,543,314,200 |
|
|
Indirect Value
|
$7,622,100,274 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$10,165,414,474 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-07-08 |
4 |
B |
$4.25 |
$14,450 |
I/I |
3,400 |
5,586,600 |
1.5 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-07-08 |
4 |
B |
$2.99 |
$245,799 |
I/I |
82,100 |
4,291,674 |
1.5 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-07-09 |
4 |
B |
$3.04 |
$2,434,112 |
I/I |
800,300 |
5,091,974 |
1.5 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-07-10 |
4 |
B |
$3.03 |
$1,221,615 |
I/I |
403,200 |
5,495,174 |
1.5 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-07-11 |
4 |
B |
$3.07 |
$38,373 |
I/I |
12,500 |
5,507,674 |
1.5 |
- |
|
SGXP |
Sgx Pharmaceuticals, Inc. |
Indirect Beneficial Owner |
|
2008-08-20 |
4 |
D |
$3.00 |
$16,523,022 |
I/I |
(5,507,674) |
0 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-09-19 |
4 |
S |
$8.55 |
$1,638,621 |
I/I |
(191,600) |
4,666,315 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-09-22 |
4 |
S |
$8.72 |
$2,468,768 |
I/I |
(283,200) |
4,383,115 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-07 |
4 |
B |
$0.66 |
$518,003 |
I/I |
790,000 |
4,897,899 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-08 |
4 |
B |
$0.62 |
$63,829 |
I/I |
103,100 |
5,000,999 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-10 |
4 |
B |
$0.60 |
$34,893 |
I/I |
58,300 |
5,059,299 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-10-10 |
4 |
B |
$2.72 |
$1,215,968 |
I/I |
447,047 |
5,658,647 |
1.5 |
- |
|
CAPS |
Capstone Therapeutics Cor... |
Indirect Beneficial Owner |
|
2008-10-10 |
4 |
B |
$0.58 |
$136,753 |
I/I |
237,500 |
4,187,788 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-13 |
4 |
B |
$0.65 |
$16,550 |
I/I |
25,500 |
5,084,799 |
1.5 |
- |
|
CAPS |
Capstone Therapeutics Cor... |
Indirect Beneficial Owner |
|
2008-10-13 |
4 |
B |
$0.63 |
$1,638 |
I/I |
2,600 |
4,190,388 |
1.42 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-13 |
4 |
B |
$3.24 |
$157,305 |
I/I |
48,500 |
4,428,032 |
1.5 |
- |
|
CAPS |
Capstone Therapeutics Cor... |
Indirect Beneficial Owner |
|
2008-10-14 |
4 |
B |
$0.63 |
$598,083 |
I/I |
946,500 |
5,136,888 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-14 |
4 |
B |
$3.15 |
$26,775 |
I/I |
8,500 |
4,436,532 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-15 |
4 |
B |
$3.08 |
$156,983 |
I/I |
51,000 |
4,487,532 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-15 |
4 |
B |
$0.65 |
$462,800 |
I/I |
712,000 |
5,796,799 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-16 |
4 |
B |
$0.65 |
$1,320,150 |
I/I |
2,031,000 |
7,827,799 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-16 |
4 |
B |
$3.12 |
$58,919 |
I/I |
18,900 |
4,506,432 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-22 |
4 |
B |
$3.24 |
$231,372 |
I/I |
71,400 |
4,577,832 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-23 |
4 |
B |
$3.22 |
$426,099 |
I/I |
132,300 |
4,710,132 |
1.5 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-27 |
4 |
B |
$3.12 |
$201,192 |
I/I |
64,400 |
4,774,532 |
1.5 |
- |
|
195 Records found
|
|
Page 5 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|